Chronic Pentamidine Aerosol Prophylaxis Does Not Induce QT Prolongation *

Chronic Pentamidine Aerosol Prophylaxis Does Not Induce QT Prolongation *

©linical Volume 71 -1993 Investigator Continuation of Klinische Wochenschrift ij Uta* G 2- &<? Editor in Chief N. Zöllner, Munich Associate Editor U. Gresser, Munich 19 $3 • -7 - Editorial Board G. Seifert, Hamburg Mainz G.Adler, Ulm J. Shepherd, Glasgow M.J. Mihatsch, Basle M.E. Bertrand, Lille H. B. Stähelin, Basle B. S. Mitchell, Chapel Hill T. Brandt, Munich K.-H. Usadel, Frankfurt a.M. C. Mueller-Eckhardt, Gießen V. Diehl, Cologne G. Vantrappen, Louvain O.-A. Müller, Munich Ε. Erdmann, Munich R von Wiehert, Marburg J.G. Puig, Madrid W. Gerok, Freiburg K.G. Wormsley, Dundee E.O. Riecken, Berlin G. Giebisch, New Haven E. Ritz, Heidelberg F. -D. Goebel, Munich Advisory Board R. Ritz, Basle D. Häussinger, Freiburg S. Sacks, London R. Arnold, Marburg H. Kaess, Munich H. Schuster, Munich J.R. Kalden, Erlangen W.G. Daniel, Hannover H.-R Schuster, Hildesheim G. J. Krejs, Graz J. Dichgans, Tübingen W. Seeger, Glessen W. Kubier, Heidelberg A. Distler, Berlin H.-G. Sieberth, Aachen H. Löffler, Kiel H. L Fehm, Lübeck R-A. Spengel, Munich F. Loogen, Düsseldorf R. Ferlinz, Mainz G. Steinbeck, Munich W. Lorenz, Marburg O. Götze, Göttingen J.A.Tischfield, Indianapolis J. Lubsen, Rotterdam RA. Gries, Düsseldorf G. Utermann, Innsbruck P.M. Mannucci, Milan W.L. Gross, Lübeck/Bad Bramstedt H. Vetter, Bonn RA. Miescher, Geneva E.G. Hahn, Erlangen C. Wagener, Hamburg G. Paumgartner, Munich H.-L. Hahn, Wiesbaden M. Wienbeck, Augsburg D. Hoelzer, Frankfurt a.M. H. D. Pohle, Berlin G. Wolfram, Munich C. Keller, Munich D.L. Scott, London R. Ziegler, Heidelberg RC. Scriba, Munich HJ. Kramer, Bonn Springer International Continuation of Klinische Wochenschrift Founded in 1922. Edited by V. Salle, A. Gottstein, A. von Domaris, P. Jungmann, C. von Noorden, H. Schwiegk, among others. From 1926, official journal of the Gesellschaft Deutscher Naturforscher und Ärzte. Berlin, Springer, and Munich, J.F. Bergmann. Was the continuation of the Berliner Klinische Wochenschrift, edited from 1864 to 1920 by L.C. Posner, L. Waldenburg, and CA. Ewald, etc. and published by A. Hirschwald in Berlin, and Therapeutischen (Halb-)Monatsheft, edited by W. Heubner, L. Langstein, and E. Meyer, 1887-1921, Springer, Berlin. Copyright Submission of a manuscript implies: that the work described has not been published before (except in the form of an abstract or as part of a published lecture, review or thesis), that it is not under consideration for publication elsewhere; that its publication has been approved by all coauthors, if any, as well as by the responsible authorities at the institute where the work has been carried out; that, if and when the manuscript is accepted for publication, the authors agree to automatic transfer of the copyright to the publisher; and that the manuscript will not be published elsewhere in any language without the consent of the copyright holders. All articles published in this journal are protected by copyright, which covers the exclusive rights to reproduce and distribute the article (e.g., as offprints), as well as all translation rights. No material published in this journal may be reproduced photographically or stored on microfilm, in electronic data bases, video disks, etc., without first obtaining written permission from the publisher. The use of general descriptive names, trade names, trademarks, etc., in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations. While the advice and information in this journal is believed to be true and accurate at the date of its going to press, neither the authors, the editors, nor the publisher can accept any legal responsibility for any errors or omissions that may be made. The publisher makes no warranty, express or implied, with respect to the material contained herein. Special regulations for photocopies in the USA: Photocopies may be made for personal or in-house use beyond the limitations stipulated under Section 107 or 108 of U.S. Copyright Law, provided a fee is paid. All fees should be paid to the Copyright Clearance Center, Inc., 21 Congress Street, Salem, MA 01970, USA, stating the ISSN 0941-0198, the volume, and the first and last page numbers of each article copied. The copyright owner's consent does not include copying for general distribution, promotion, new works, or resale. In these cases, specific written permission must first be obtained from the publisher. Printers: Universitätsdruckerei Η. Stürtz AG, Würzburg © Springer-Verlag Berlin Heidelberg 1993 Printed in Germany Bianchi L -* Reichen J Contents of Volume 71 Biber J Murer Η Bieg S -* Kling Ε No 1: pp 1- 90 published January 22, 1993 Birbamer G Berek Κ No 2:pp 91- 176 published February 8, 1993 Birk A -* Kiese wetter Η No 3: pp 177- 256 published March 4, 1993 Bittinger A -> Wagner U No 4: pp 257- 338 published April 1, 1993 Bleich Μ -»> Greger R No 5: pp 339- 420 published May 3, 1993 Blind Ε, Raue F, Meinel T, Bucher M, No 6: pp 421- 504 published June 9, 1993 Manegold C, Ebert W, Vogt-Moykopf I, No 7: pp 505- 586 published July 5, 1993 Ziegler R: Levels of parathyroid hor­ No 8: pp 587- 672 published August 9, 1993 mone-related protein in hypercalcemia No 9: pp 673- 762 published September 1, 1993 of malignancy: comparison of midre- No 10: pp 763- 874 published October 1,1993 gional radioimmunoassay and two-site No 11: pp 875- 962 published November 2, 1993 immunoradiometric assay 31 No 12: pp 963-1022 published December 2, 1993 Blume J -* Kiesewetter Η Supplement to Volume 71/lssue 5: Renin-angiotensin-system and collagen metabolism Bock HL Nothdurft HD in diabetes mellitus and arterial hypertension, Heidelberg, November 6-8, 1992 Boehm BO, Farid NR: Molecular aspects Supplement to Volume 71/lssue 8: Seventh International Symposium on The Biomedical of endocrine autoimmunity 79 and Clinical Aspects of Coenzyme Q, Copenhagen, September 18-19, 1992 Boehm BO, Kühnl Ρ, Löliger C, Ketzler- Sasse U, Holzberger G, Seidl S, Bäuerle R, Schifferdecker Ε, Usadel KH: HLA- DR3 and HLA-DR5 confer risk for au­ toantibody positivity against the thyro- peroxidase (mic-TPO) antigen in healthy blood donors 221 Abedinpour F Weber MM Ball F Böhles Η Boehme Μ -> Kling Ε Adelmann Β -> Weber MM Banos V ->· Gomez J Bogner JR -> Papakonstantinou G Adler G -• Scherbaum WA Barrett PHR -• Parhofer KG Bogner JR -> Thalhammer C Aguilar-Martinez JL Cantero-Hinojosa Barrio J -*• Domingo Ρ Bohle A -* Kirsten D J Barth PJ Wagner U Böhles Η, Aschenbrenner Μ, Roth Μ, Albrecht H, Stellbrink H-J, Fenske S, Koch Baschieri L -»· Monzani F Loewenich V ν, Ball F, Usadel KH: De­ J, Greten H: A novel variety of atypical Bassermann R Dörfler Η velopment of thyroid gland volume dur­ Pneumocystis carinii infection after Bäuerle R -> Boehm BO ing the first 3 months of life in breast-fed longterm prophylactic pentamidine in­ Baum Κ -• Essfeld D versus iodine-supplemented and iodine- halation in an AIDS patient: large lower Baumann Μ ->> Graeve L free formula-fed infants 13 lobe pneumocystoma 310 Baumbach A -> Preisack MB Bokemeyer D -> Meyer-Lehnert Η Albrecht Η Plettenberg A Baumert T, Kleber G, Schwarz J, Stäbler Bollensen Ε, Menck S, Buzanoski J, Alexander GJM Arnold JC A, Lamerz R, Mann K: Reversible hyper• Prange HW: Iatrogenic epidural spinal Algra A Oddens BJ kinesia in a patient with autoimmune po• abscess 780 Allende MT Collazos J lyglandular syndrome type I 924 Borlinghaus P, Wieser S, Lamerz R: Epi­ Allgayer Η -» Scheurlen C Baumgarten R von Hofstetter-Degen Κ dermal growth factor, transforming Allolio Β Lehmann R Baumgarten R von ->· Wetzig J growth factor-or, and epidermal growth Althoff P-H -> Rau Η Baur Μ -»· Glasbrenner Β factor receptor content in normal and Ammon A, Eiffert H, Reil S, Beyer J-H, Bause HW Scholz J carcinomatous gastric and colonic tis­ Droese M, Hiddemann W: Tumor-asso­ Beaujean R -> Reitz G sue 903 ciated antigens in effusions of malignant Bechtel U -+ Christ Μ Borst HG, Schäfers H-J: Lung transplanta• and benign origin 437 Beck M, Valadares ER, Lötz J: Gaucher's tion 98 Andreas S, Breska Β von, Kopp Ε, Figulla disease: therapy by intravenous infu• Brandis Μ, Hardt Κ ν d, Zimmerhackl RB, HR, Kreuzer Η: Periodic respiration in sions of modified glucocerebrosidase Mohrmann Μ, Leititis J: Cytostatics - in­ patients with heart failure 281 78 duced tubular toxicity 855 Appenheimer Μ -> Ko Υ Becker Η -> Gross-Weege W Brandis Μ Pfleiderer S Arnim Τ von Pliml W Becker W -> Raue F Brandl Η -• Ritter C von Arnold JC, Nouri-Aria KT, O'Grady JG, Beimpold Η -> Wiedermann CJ Braun W -» Weber Β Portmann BC, Alexander GJM, Williams Bein Β -»· Sailer Β Braunsteiner Η -> Wiedermann CJ R: Hepatic α-interferon expression in cy- Benker G Jaspers C Brecht-Krauß D Glasbrenner Β tomegalovirus-infected liver allograft Benker G -• Petrasch SG Breckenridge A: Clinical pharmacology in recipients with and without vanishing Benning Κ -• Müller-Ladner U the 1990s: a personal perspective 478 bile duct syndrome 191 Berchtenbreiter U -+ Körting HC Breska Β von -* Andreas S Aschenbrenner Μ -> Böhles Η Berek Κ, Kiechl S, Willeit J, Birbamer G, Brodersen H-P -» Holtkamp W Athanasiadis A -> Preisack MB Vogl G, Schmutzhard E: Subarachnoid Brosen K: The pharmacogenetics of the hemorrhage as presenting feature of selective serotonin reuptake inhibitors Baartz F-J -»· Kirsch ΚΑ isolated neurosarcoidosis 54 1002 Bach D -»· Heering Ρ Bergelson LD: Gangliosides and antitu­ Bucher Μ Blind Ε Bach R Jung F mor immunity 590 Buettner UW -* Stumvoll Μ Badenhoop Κ -> Rau Η Berger J -*· Lenzhofer R

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    18 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us